c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells

被引:48
|
作者
Chai, YL [1 ]
Chipitsyna, G [1 ]
Cui, JQ [1 ]
Liao, BS [1 ]
Liu, S [1 ]
Aysola, K [1 ]
Yezdani, M [1 ]
Reddy, ESP [1 ]
Rao, VN [1 ]
机构
[1] Med Coll Penn & Hahnemann Univ, Ctr Canc, Dept Med, Program Canc Genet, Philadelphia, PA 19102 USA
关键词
c-Fos; BRCA1/BRCA1a/1b; Elk-1; growth suppression; breast cancer; protein-protein interaction;
D O I
10.1038/sj.onc.1204256
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Elk-1, a c-Fos protooncogene regulator, which belongs to the ETS-domain family of transcriptional factors, plays an important role in the induction of immediate early gene expression in response to a variety of extracellular signals. In this study, we demonstrate for the first time the in, vitro and in vivo interaction of Elk-1 with BRCA1 splice variants BRCA1a and BRCA1b using GST-pull down assays, co-imunoprecipitations/Western blot analysis of cell extracts from breast cancer cells and mammalian two-hybrid assays. We have localized the BRCA1 interaction domain of Elk-1 protein to the conserved ETS domain, a motif involved in DNA binding and protein-protein interactions. We also observed binding of BRCA1 proteins to other ETS-domain transcription factors SAP1, ETS-1, ERG-2 and Fli-1 but not to Elk-1 splice variant Delta Elk-1 and c-Fos protooncogene, Both BRCA1a and BRCA1b splice variants function as growth suppressors of human breast cancer cells. interestingly, our studies reveal that although both Elk-1 and SAP-1 are highly homologous members of a subfamily of ETS domain proteins called ternary complex factors, it is only Elk-1 but not SAP-I that can augment the growth suppressive function of BRCA1a/1b proteins in breast cancer cells, Thus Elk-1 could be a potential downstream target of BRCA1 in its growth control pathway, Furthermore, we hare observed inhibition of c-Fos promoter activity in BRCA1a transfected stable breast cancer cells and over expression of BRCA1a/1b attenuates MEK-induced SRE activation in vivo. These results demonstrate for the first time a link between the growth suppressive function of BRCA1a/1b proteins and signal transduction pathway involving Elk-1 protein, All these results taken together suggest that one of the mechanisms by which BRCA1a/1b proteins function as growth/tumor suppressors is through inhibition of the expression of Elk-1 target genes like c-Fos.
引用
收藏
页码:1357 / 1367
页数:11
相关论文
共 50 条
  • [31] Breast cancer risk associated with BRCA1 and BRCA2 pathogenic variants in the Eastern Chinese population
    Yu, Sanjian
    Qiu, Xia
    Wang, Zezhou
    Xiao, Jialong
    Ji, Hui
    Shan, Hailin
    Shao, Qing
    Xia, Heng
    Cao, Feng
    Li, Jun
    Fu, Cuixia
    Chen, Liqin
    Lu, Xiaofang
    Su, Tingting
    Yu, Qianqian
    Hou, Shengqun
    Wang, Honglian
    Zheng, Ying
    Shao, Zhimin
    Liu, Yun
    Hu, Zhen
    CANCER PATHOGENESIS AND THERAPY, 2025, 3 (02): : 147 - 153
  • [32] BRCA1 and Estrogen Receptor α Expression Regulation in Breast Cancer Cells
    A. M. Scherbakov
    E. A. Shestakova
    K. E. Galeeva
    T. A. Bogush
    Molecular Biology, 2019, 53 : 442 - 451
  • [33] Breast cancer risk associated with BRCA1/2 variants in the Pakistani population
    Abbas, Saba
    Siddique, Ayesha
    Shahid, Naeem
    Khan, Rabbia Tariq
    Fatima, Warda
    BREAST CANCER, 2019, 26 (03) : 365 - 372
  • [34] BRCA1 and Estrogen Receptor Expression Regulation in Breast Cancer Cells
    Scherbakov, A. M.
    Shestakova, E. A.
    Galeeva, K. E.
    Bogush, T. A.
    MOLECULAR BIOLOGY, 2019, 53 (03) : 442 - 451
  • [35] Functional Analysis of BRCA1 3'UTR Variants Predisposing to Breast Cancer
    Sierra-Diaz, Diana Carolina
    Cabrera, Rodrigo
    Gonzalez-Vasquez, Laura Alejandra
    Angulo-Aguado, Mariana
    Llinas-Caballero, Kevin
    Fonseca-Mendoza, Dora Janeth
    Contreras-Bravo, Nora Constanza
    Restrepo, Carlos Martin
    Ortega-Recalde, Oscar
    Morel, Adrien
    APPLICATION OF CLINICAL GENETICS, 2024, 17 : 57 - 62
  • [36] Breast cancer risk associated with BRCA1/2 variants in the Pakistani population
    Saba Abbas
    Ayesha Siddique
    Naeem Shahid
    Rabbia Tariq Khan
    Warda Fatima
    Breast Cancer, 2019, 26 : 365 - 372
  • [37] Pyrosequencing analysis of BRCA1 methylation level in breast cancer cells
    Cai, Fengfeng
    Ge, Isabell
    Wang, Minghong
    Biskup, Ewelina
    Lin, Xiaoyan
    Zhong, Xiaoyan
    TUMOR BIOLOGY, 2014, 35 (04) : 3839 - 3844
  • [38] Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue
    Bhavani, V.
    Srinivasulu, M.
    Ahuja, Y. R.
    Hasan, Q.
    CANCER BIOMARKERS, 2009, 5 (4-5) : 207 - 213
  • [39] Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer
    Madar, Laszlo
    Majoros, Viktoria
    Szucs, Zsuzsanna
    Nagy, Orsolya
    Babicz, Tamas
    Butz, Henriett
    Patocs, Attila
    Balogh, Istvan
    Koczok, Katalin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [40] Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancer
    Mampel, Alejandra
    Sottile, Mayra L.
    Denita-Juarez, Silvina P.
    Vargas, Ana L.
    Vargas-Roig, Laura M.
    CANCER GENETICS, 2022, 260 : 14 - 17